Earnings History Data for CytomX Therapeutics, Inc. (CTMX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

CytomX Therapeutics, Inc.

CytomX Therapeutics, Inc. is an oncology focused biopharmaceutical company. The Company is engaged in developing Probody(TM) therapeutics for the treatment of cancer. Its pipeline focuses areas consist of Precision cancer immunotherapy and Probody drug conjugates. CytomX Therapeutics, Inc. is headquartered in South San Francisco, California.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
07-11-2023 AH CTMX CytomX Therapeutics, Inc. 84.13 0.04 -0.17 -0.35 CytomX GAAP EPS of $0.04 beats by $0.21, revenue of $26.38M beats by $12.97M
[11/7/2023 4:41 PM]
1.27 -0.01 
(-0.78%)
1.29 0.01 
(0.78%)
1.04 - 3.02 300,822 220,000 5,155
08-08-2023 AH CTMX CytomX Therapeutics, Inc. 112.11 -0.02 -0.19 -0.37 CytomX Non-GAAP EPS of -$0.02 beats by $0.18, revenue of $24.72M beats by $10.98M
[8/8/2023 4:44 PM]
1.64 -0.05 
(-2.96%)
1.68 -0.01 
(-0.59%)
1.17 - 3.02 354,326 240,000 1,019
09-05-2023 AH 4:10 PM ET
(May 9)
CTMX CytomX Therapeutics, Inc. 112.59 -0.05 -0.16 -0.37 CytomX GAAP EPS of -$0.05 beats by $0.06, revenue of $23.5M beats by $3.59M
[5/9/2023 5:58 PM]
1.82 0.10 
(5.81%)
1.72 0.0 
(0.00%)
1.17 - 3.02 1,633,101 340,000 1,433
27-03-2023 AH 4:10 PM ET
(Mar 27)
CTMX CytomX Therapeutics, Inc. 148.69 -0.42 -0.21 -0.40 CytomX GAAP EPS of -$1.51 misses by $0.24, revenue of $53.16M misses by $18.91M
[3/27/2023 4:17 PM]
1.51 -0.28 
(-15.64%)
1.49 -0.30 
(-16.76%)
1.17 - 3.02 2,900,128 1,140,000 125,379
08-11-2022 AH 4:15 PM ET
(Nov 8)
CTMX CytomX Therapeutics, Inc. 82.44 -0.35 -0.32 -0.35 CytomX GAAP EPS of -$0.35 misses by $0.05, revenue of $16.92M misses by $3.13M
[11/8/2022 5:11 PM]
1.23 0.0 
(0.00%)
1.21 -0.02 
(-1.63%)
1.17 - 7.53 506,822 260,000 44,487
04-08-2022 AH 4:15 PM ET
(Aug 4)
CTMX CytomX Therapeutics, Inc. 94.83 -0.37 -0.36 -0.30 CytomX GAAP EPS of -$0.37 misses by $0.02, revenue of $18.17M misses by $0.21M
[8/4/2022 4:36 PM]
1.67 0.04 
(2.45%)
1.58 -0.05 
(-3.07%)
1.19 - 7.53 1,421,093 1,280,000 22,093
05-05-2022 AH 4:15 PM ET
(May 5)
CTMX CytomX Therapeutics, Inc. 119.03 -0.37 -0.35 -0.26 CytomX GAAP EPS of -$0.37 misses by $0.01, revenue of $17.13M misses by $4.12M
[5/5/2022 4:25 PM]
1.62 0.02 
(0.93%)
1.74 0.13 
(8.07%)
1.52 - 8.95 844,019 1,510,000 1,215
01-03-2022 AH 4:15 PM ET
(Mar 1)
CTMX CytomX Therapeutics, Inc. 262.95 -0.40 -0.22 -0.31 CytomX GAAP EPS of -$1.30 misses by $0.13, revenue of $69.57M misses by $5.85M
[3/1/2022 4:50 PM]
4.03 0.49 
(13.84%)
3.82 0.28 
(7.91%)
3.52 - 10.05 963,016 500,000 1,016
04-11-2021 AH 4:15 PM ET
(Nov 4)
CTMX CytomX Therapeutics, Inc. 370.09 -0.35 -0.30 -0.32 CytomX EPS beats by $0.65, misses on revenue
[11/4/2021 4:18 PM]
6.57 0.59 
(9.87%)
5.98 0.0 
(0.00%)
4.28 - 10.05 671,173 730,000 35,525
05-08-2021 AH 4:15 PM ET
(Aug 5)
CTMX CytomX Therapeutics, Inc. 373.16 -0.30 -0.26 -0.34 CytomX EPS in-line, misses on revenue
[8/5/2021 4:55 PM]
5.22 -0.56 
(-9.76%)
5.55 -0.24 
(-4.15%)
5.20 - 10.05 1,221,070 460,000 2,671
06-05-2021 AH 4:15 PM ET
(May 6)
CTMX CytomX Therapeutics, Inc. 559.09 -0.26 -0.29 0.26 CytomX EPS beats by $0.06, misses on revenue
[5/6/2021 4:27 PM]
8.56 0.41 
(4.97%)
8.25 0.10 
(1.23%)
6.25 - 15.44 585,078 1,600,000 308,261
24-02-2021 AH 4:15 PM ET
(Feb 24)
CTMX CytomX Therapeutics, Inc. 526.76 -0.31 -0.35 -0.79 CytomX beats on revenue
[2/24/2021 4:30 PM]
7.90 -0.14 
(-1.74%)
8.50 0.46 
(5.72%)
3.60 - 15.44 603,543 835,088 410
05-11-2020 AH 4:15 PM ET
(Nov 5)
CTMX CytomX Therapeutics, Inc. 310.87 -0.32 -0.36 -0.52 CytomX EPS beats by $0.11, beats on revenue
[11/5/2020 4:38 PM]
7.00 -0.07 
(-0.99%)
7.48 0.41 
(5.80%)
3.60 - 15.44 267,067 425,719 2,275
06-08-2020 AH 4:10 PM ET
(Aug 6)
CTMX CytomX Therapeutics, Inc. 338.45 -0.34 0.34 -0.64 CytomX EPS misses by $0.83, misses on revenue
[8/6/2020 4:29 PM]
7.85 0.30 
(3.97%)
7.15 -0.40 
(-5.30%)
3.60 - 15.44 216,340 472,016 12,470